Epidemiology of hepatitis B infection in the Western Pacific and South East Asia

Gut

Volumn 38, Issue SUPPL. 2, 1996, Pages

  Gust, I D ^a  

^a CSL LIMITED   (Australia)

Author keywords

epidemiology; hepatitis B; immunisation; South East Asia; Western Pacific

Indexed keywords

ARTICLE; FAR EAST; GEOGRAPHIC DISTRIBUTION; HEPATITIS B; HUMAN; IMMUNIZATION; INFECTION CONTROL; INFECTION RISK; PRIORITY JOURNAL;

EID: 0029893071     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.38.Suppl_2.S18     Document Type: Article

References (50)

1. Blumberg BS, Alter HJ, Visnich S. A 'new' antigen in leukaemia sera. JAMA 1965; 191: 541.
2. Beasley RP, Trepo C, Stevens CE, et al. The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol 1977; 105: 94-8.
3. Stevens CE, Taylor PE, Tong MJ, et al. Prevention of perinatal hepatitis B virus infection with hepatitis B immune globulin and hepatitis B vaccine. In: Zuckerman AJ, ed. Viral hepatitis and liver disease. New York: Alan R Liss, 1988: 982-8.
4. Beasley RP, Lin CC, Hwang LY, et al. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22 707 men in Taiwan. Lancet 1981; ii: 1129-33.
5. Obata H, Hayashi N, Motoike Y. A prospective study of development of hepatocellular carcinoma from liver cirrhosis with persistent hepatitis B virus infection. Int J Cancer 1980; 25: 741.
6. Xu Z-Y, Xi L-F, Fu T-Y, Zhou D-K. Cost-benefit and decision analysis of hepatitis B immunisation. Shanghai J Prevent Med 1989; 1: 24-7.
7. Speed BR, Dimitrakakis M, Thoma K, Gust ID. Control of HBV and HDV in an isolated Pacific island: I. Pattern of infection. J Med Virol 1989; 29: 13-9.
8. Gust ID. Global perspective of viral hepatitis and liver disease: the Western Pacific. In: Nishioka K, et al, eds. Viral hepatitis and liver disease. Tokyo: Springer-Verlag, 1994: 390-3.
9. Sung JL and the Asian Regional Study Group. Hepatitis B virus eradication strategy for Asia. Vaccine 1990; 8 (suppl): S95-9.
10. Domingo E, Lansang MA, Ramirez B, et al. Viral hepatitis in the Philippines: a perspective. In: Nishioka K, et al, eds. Viral hepatitis and liver disease. Tokyo: Springer-Verlag, 1994: 400-2.
11. Liaw Y-F. Viral hepatitis in Taiwan: status in the 1990s. In: Nishioka K, et al, eds. Viral hepatitis and liver disease. Tokyo: Springer-Verlag, 1994: 419-21.
12. Sulaiman HA. Hepatitis in Indonesia. In: Nishioka K, et al, eds. Viral hepatitis and liver disease. Tokyo: Springer-Verlag, 1994: 394-6.
13. Thompson S, Ruff T. Hepatitis B vaccination: what are the current international recommendations? Clin Immunother 1995; 3: 15-26.
14. Suzuki H. Viral hepatitis in Japan. In: Nishioka K, et al, eds. Viral hepatitis and liver disease. Tokyo: Springer-Verlag, 1994: 426-8.
15. Tandon BN, Acharya SK, Dasarathy S, et al. Viral hepatitis in India. In: Nishioka K, et al, eds. Viral hepatitis and liver disease. Tokyo: Springer-Verlag, 1994: 397-9.
16. Tao Q-M, et al. Epidemiology of hepatitis B and C in China. In: Nishioka K, et al, eds. Viral hepatitis and liver disease. Tokyo: Springer-Verlag, 1994: 412-5.
17. Hui Z, Coulepis AG, Zimmet P, et al. Seroepidemiology of infection with hepatitis B virus in Fiji. Am J Epidemiol 1982; 116: 608-16.
18. Milne A, Allwood GR, Moyes CD, et al. Prevalence of hepatitis B infections in a multiracial New Zealand community. NZ Med J 1985; 98: 529-32.
19. Wan X, Currie B, Miller N, Mathews JD. Acute hepatitis B infection in aboriginal Australians. Aust J Publ Health 1993; 17: 331-3.
20. Gust ID. Control of hepatitis B in Australia: the case for alternative strategies. Med J Aust 1992; 156: 819-21.
21. Gust ID, Dimitrakakis M, Zimmet P. Studies on hepatitis B surface antigen and antibody in Nauru. I. Distribution among Nauruans. Am J Trop Med Hyg 1978; 27: 1030-6.
22. Tsen YJ, Chang MH, Hsu HY, et al. Seroprevalence of hepatitis B virus infections in children in Tapei, 1989: five years after a mass hepatitis B vaccination programme. J Med Virol 1991; 34: 96-9.
23. Shiraki K. Vertical transmission of hepatitis B virus and its prevention in Japan. In: Nishioka K, et al, eds. Viral hepatitis and liver disease. Tokyo: Springer-Verlag, 1994: 530-2.
24. Lucas CR, Milne A, Hopkirk N. Kawerau revisited: hepatitis A and B seroprevalence in 1984 and 1993. NZ Med J 1994; 197: 206-8.
25. Speed BR. Republic of Nauru: report on hepatitis B vaccination programme June 1983 to May 1990. Fairfield Hospital, June 1993.
26. Evaluation of the long-term efficacy of hepatitis B vaccination programme in the prevention of chronic carriage of hepatitis B virus. Epidemiological News Bulletin, Singapore 1994; 20: 7-10.
27. Gust ID, Dimitrakakis M, Zimmet P. Studies on hepatitis B surface antigen and antibody in Nauru. II. Distribution in Gilbert and Ellice (Tuvalu) islanders. Am J Trop Med Hyg 1978; 27: 1206-9.
28. Gust ID, Lehmann NI, Dimitrakakis M, Zimmet P. A seroepidemiologic study of hepatitis A and B infection in an isolated Pacific population. J Infect Dis 1979; 139: 559-63.
29. Xu Z-Y. Epidemiology of hepatitis B. In: Wen Y-M, et al, eds. Viral hepatitis in China: problems and control strategies. Monogr Virol. Basel: Karger, 1992; 19: 99-110.
30. Hwang L-Y, Lee C-Y, Beasley RP. Five-year follow-up of HBV vaccination with plasma-derived vaccine in neonates: evaluation of immunogenicity and efficacy against perinatal transmission. In: Hollinger FB, Lemon SM, Margolis HS, eds. Viral hepatitis and liver disease. Baltimore: Williams and Wilkins, 1991: 759-61.
31. Gilbert GL. Prevention of vertical transmission of hepatitis B. Med J Aust 1984; 141: 213-6.
32. André FE, Zuckerman AJ. Review: protective efficacy of hepatitis B vaccines in neonates. J Med Virol 1994; 44: 144-51.
33. Milne A. Viral hepatitis in the Eastern Bay of Plenty. NZ Med J 1980; 92: 85-7.
34. Campbell DH, Sargent JW, Plant AJ. The prevalence of markers of infection with hepatitis B virus in a mixed-race Australian community. Med J Aust 1989; 150: 489-92.
35. Burgess MA, McIntosh EDG, Allars HM, Kenrick KG. Hepatitis B in urban Australian schoolchildren: no evidence of horizontal transmission between high-risk and low-risk groups. Med J Aust 1993; 159: 315-9.
36. Muraskin W. The war against hepatitis B. A history of the international task force for hepatitis B immunisation. Philadelphia: University of Pennsylvania Press, 1995: 1-248.
37. Milne A. Hepatitis B vaccination in New Zealand. Aust J Publ Health 1993; 17: 398.
38. Ruff TA, Gertig DM, Otto BF, et al. Lombok hepatitis B model immunisation project: toward universal infant hepatitis B immunisation in Indonesia. J Infect Dis 1995; 171: 290-6.
39. Wong WCW, Tsang KK. A mass hepatitis B vaccination programme in Taiwan: its preparation, results and reasons for uncompleted vaccinations. Vaccine 1994; 12: 229-34.
40. Chainuvati T. Perspective of viral hepatitis in Thailand. In: Nishioka K, et al, eds. Viral hepatitis and liver disease. Tokyo: Springer-Verlag, 1994: 403-5.
41. World Bank. World Development Report 1993. New York: Oxford University Press, 23.
42. Carman WF, Jacyna MR, Hadziyannis S, et al. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 1989; ii: 588-91.
43. Kosaka V, Takase K, Kojima M, et al. Fulminant hepatitis B: induction by hepatitis B virus mutants defective in the precore region and incapable of encoding e antigen. Gastroenterology 1991; 100: 1087-94.
44. Omata M, Ehata T, Yokosuka O, et al. Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Engl J Med 1991; 324: 1690-704.
45. Hsu H-Y, Chang M-H, Lee C-Y, et al. Precore mutant of hepatitis B virus in childhood fulminant hepatitis B: an infrequent association. J Infect Dis 1995; 171: 776-81.
46. Laskus T, Persing DH, Nowicki MJ, et al. Nucleotide sequence analysis of the precore region in patients with fulminant hepatitis B in the United States. Gastroenterology 1993; 105: 1173-8.
47. Dimitrakakis M, Gust ID. HDV Infection in the Western Pacific Region. In: Gerin JL, Purcell RH, Rizzetto M, eds. The hepatitis delta virus. New York: Wiley-Liss, 1991: 89-96.
48. Beasley RP, Hwang LY, Lee GC, et al. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immunoglobulin and hepatitis B vaccine. Lancet 1983; ii: 1099.
49. Beasley RP, Hwang LY, Lin CC, et al. Hepatitis B immunoglobulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Lancet 1981; ii: 388-93.
50. Beasley RP, Hwang LY, Stevens CE, et al. Efficacy of hepatitis B immunoglobulin (HBIG) for prevention of perinatal transmission of the HBV carrier state: final report of a randomised, double-blind placebo-controlled trial. Hepatology 1983; 3: 135-41.